Pharmacotherapy Intensive Studies (L259179)
ACPE Numbers: Various – see listing below
Content Release Date: December 17, 2025
Expiration Date: December 15, 2026
Activity Type: Application-based
CE Credits: 6 contact hours
Activity Fee: $140 (ASHP member); $205 (non-member)
Activity Overview
These activities were presented as part of the 2025 Midyear Clinical Meeting. Learners who claimed ACPE credit for these activities as part of that meeting should not claim ACPE credit again.
The Intensive Studies Package is intended for board-certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in pharmacotherapy.
The Pharmacotherapy Intensive Studies Recertification Package consists of 4 activities (see table below) and provides up to 6.0 contact hours of continuing pharmacy education and/or recertification credit.
These activities are part of the ASHP professional development program for BCPS recertification approved by BPS.
Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
Target Audience
These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:
- Managing menopausal symptoms, such as hot flashes, night sweats, genitourinary syndrome of menopause, and mood disturbances COPD management strategies
- Comprehensive management of cardiovascular risk factors among people with HIV
- Developing institutional pathways/protocols to minimize cardiovascular risk in the perioperative setting.
- Pharmacogenomics amongst health system pharmacists
Recertification Credit
Board-Certified pharmacists are eligible to receive up to 6.0 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.
ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.
ASHP is approved by BPS as a provider for the recertification of BCPS.
|
Learning Activity |
Passing Score |
Credit Information |
|
What’s Hot? Evidence-Based Updates in Menopause Care |
60% |
1.5 Contact Hours BPS: BCPS |
|
Don't Forget the HeART - Managing Cardiovascular Risk Among People with HIV |
71% |
1.5 Contact Hours BPS: BCPS |
|
Perioperative Cardiovascular Management for Noncardiac Surgery |
69% |
1.5 Contact Hours BPS: BCPS ACPE: 0204-0000-25-283-H01-P |
| An Ace in the Hole: Improving Depression Treatment with Pharmacogenomics |
73% |
1.5 Contact Hours BPS: BCPS |
Learning Objectives
What’s Hot? Evidence-Based Updates in Menopause Care
ACPE #: 0204-0000-25-297-H01-P
- Describe hormonal changes that occur during menopause and associated symptoms.
- Compare and contrast the various forms of estrogen used in menopause management.
- Discuss the role of non-hormonal and complementary medications in the management of menopause symptoms.
- Given a patient case, select appropriate pharmacologic interventions for managing specific menopause symptoms.
This activity is approved for Board-Certified Pharmacotherapy Specialist (BCPS) recertification credit.
Don't Forget the HeART - Managing Cardiovascular Risk Among People with HIV
ACPE #: 0204-0000-25-327-H02-P
- Identify the pharmacological and non-pharmacological risk factors contributing to increased cardiovascular risk among people with human immunodeficiency virus (HIV).
- Develop person-centered care plans to manage chronic conditions, such as dyslipidemia, to reduce cardiovascular risk among people with HIV.
- Implement strategies to improve chronic disease management of people with HIV within clinical practice.
This activity is approved for Board-Certified Pharmacotherapy Specialist (BCPS) recertification credit.
Perioperative Cardiovascular Management for Noncardiac Surgery
ACPE #: 0204-0000-25-283-H01-P
- Apply evidence-based guidelines to assess and manage cardiovascular medication regimens for patients undergoing surgery, considering individual risk factors and surgical procedures.
- Evaluate the need for perioperative adjustment or continuation of antithrombotic therapies based on patient-specific cardiovascular risk and the type of surgery planned.
- Develop a comprehensive plan for perioperative blood pressure and lipid management, including adjustments to antihypertensive and statin therapies in high-risk cardiovascular patients.
- Integrate risk stratification tools to guide clinical decisions in adjusting cardiovascular medications during the perioperative period.
- Implement strategies to monitor and adjust cardiovascular medications in the postoperative period, ensuring appropriate transitions from hospital to home care while preventing adverse outcomes.
This activity is approved for Board-Certified Pharmacotherapy Specialist (BCPS) recertification credit.
An Ace in the Hole: Improving Depression Treatment with Pharmacogenomics
ACPE #: 0204-0000-25-247-H01-P
- Evaluate recent literature on the pharmacogenomics of antidepressant therapy and describe the strengths and limitations of clinical trials.
- Identify key gene-drug pairs from pharmacogenomic guidelines and apply pharmacogenomic results to a clinical scenario.
- List sources for reliable pharmacogenetic information and give examples of non-guideline drug-gene interactions.
- Given a patient case, apply knowledge of pharmacogenomics literature and guidelines to interpret and discuss pharmacogenomic results from a lab report.
This activity is approved for Board-Certified Pharmacotherapy Specialist (BCPS) recertification credit.
Faculty
Alexa A. Carlson, PharmD, MEd, BCPS
Associate Clinical Faculty/Clinical Pharmacist
Northeastern University/Beth Isreal Deaconess Medical Center
Boston, Massachusetts
Savanna DiCristina, PharmD, MPH, BCPS
Clinical Assistant Professor
Northeastern University
Boston, Massachusetts
Joseph A. Nardolillo, PharmD, BCACP
Assistant Professor
University of Rhode Island
Kingston, Rhode Island
Tracey H. Taveira, PharmD, CDOE
Professor and Director of Interprofessional Education/Adjunct Professor of Medicine
University of Rhode Island College of Pharmacy/Brown University
Kingston, Rhode Island/Providence, Rhode Island
Joseph Saseen, PharmD, BCPS, BCACP, FASHP
Associate Dean for Clinical Affairs and Professor
University of Colorado
Aurora, Colorado
Ashley Schenk, PharmD, BCPS, BCCP, AACC
Cardiology Clinical Pharmacist/Assistant Adjunct Professor
UK HealthCare/University of Kentucky College of Pharmacy
Lexington, Kentucky
Kayla Kreft, PharmD, BCACP
Clinical Pharmacy Specialist
University Health
San Antonio, Texas
Jordan Baye, PharmD, MA, BCPS
Associate Professor/Clinical Pharmacist
South Dakota State University College of Pharmacy & Allied Health Professions/Sanford Imagenetics
Brookings, South Dakota/Sioux Falls, South Dakota
James Stevenson, PharmD, MS, BCPP
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland
Samantha Frear, PharmD
Assistant Professor of Pharmacy Practice/Clinical Pharmacist
MCPHS/Brigham and Women’s Hospital
Boston, Massachusetts
Reviewers
Sue Dombrowski, MS, RPh
Christopher Betz, PharmD, BCPS, FASHP, FKSHP*
Snehal Bhatt, PharmD, AACC, BCPS-AQ Cardiology, FASHP*
Brooklyn Olumba, PharmD, BCPS*
Katie Lusardi, PharmD, BCIDP*
*Content Matter Experts
Field Testers
Sam Abid, PharmD, BCPS, BCEMP
Olubukola Adeyemi, PharmD, BCPS
Ally Bergman, PharmD, BCPS
Michelle Blesso, PharmD, BCPS, BCEMP
Kara Boyko Frandson, PharmD, BCPS, BCEMP
Mary Bridgeman, PharmD, BCPS, BCGP
Lindsey Buscemi, PharmD, BCPS, AAHIVP
Courtney Campbell, PharmD, BCPS, BCPPS
Anna Capulong, PharmD, BCPS, BCEMP
Anne Cetto, PharmD, BCPS
Corey Cicci, PharmD, BCPS, BCEMP
Andrew Clark, PharmD, BCPS, CDCES, CPP
Allison Clarke, PharmD, BCEMP, BCPS
Alexander Dellabella, PharmD, BCPS, BCCCP
Sonia Everhart, PharmD, BCPS, BCCCP
Allison Gorseth, PharmD, BCPS, BCEMP
Thomas Gregory, PharmD, BCPS, BCEMP
Allyson Helms, PharmD, BCPS, BCACP, MS HSPA
Carol Heunisch, BCPS BCCP
T Hodgman, Pharm D, FCCM, BCCCP BCPS
Alyssa Kiel, PharmD, BCPS, BCEMP
Michael Lake, PharmD, BCPS, BCEMP
Nancy Laux, PharmD, BCPS, BCGP
Jacky Lee, PharmD, BCPS, BCCCP
Melanie Madorsky, PharmD, BCPS, BCCP, BCCCP
Benjamin Miles, PharmD, BCPS, BCEMP
Patricya Miller, PharmD, BCPS, BCCCP, SIDP
Matthew Morrison, PharmD, BCPS, BCEMP
Mohammad Rattu, PharmD, BCOP, BCPS, BCGP
Kathryn Rolfes, PharmD, BCPS, BCCCP
Alli Rosa, PharmD, MBA, BCPS, BCCCP
Lindsay Sampson, PharmD, MS, BCPS, BCGP
Nahirony Sanchez, PharmD, BCPS, BCGP
Ashley Sii, PharmD, BCPS, BCEMP
Heather Smith, PharmD, BCPS, BCEMP
Zak Vinson, PharmD, BCPS, BCEMP
Agnes Vitarini, PharmD, BCGP, BCIDP, BCPS
Paul Wong, PharmD, BCPS, BCGP
Disclosures
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following person in control of this activity’s content has relevant financial relationships:
- Joseph Saseen: Amgen - Member, Data Safety Monitoring Board
- Katie Lusardi: Accelerate Diagnostics – Consultant
Methods and CE Requirements
Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Development
These activities were developed by ASHP.